These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8961045)

  • 1. Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamases.
    Dibdin GH; Assinder SJ; Nichols WW; Lambert PA
    J Antimicrob Chemother; 1996 Nov; 38(5):757-69. PubMed ID: 8961045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics.
    Zimmermann W
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilm and metallo beta-lactamase production among the strains of Pseudomonas aeruginosa and Acinetobacter spp. at a Tertiary Care Hospital in Kathmandu, Nepal.
    Baniya B; Pant ND; Neupane S; Khatiwada S; Yadav UN; Bhandari N; Khadka R; Bhatta S; Chaudhary R
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):70. PubMed ID: 29096652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase alteration of beta-lactam inhibitory zones.
    Tausk F; Stratton CW
    Eur J Clin Microbiol; 1987 Aug; 6(4):474-6. PubMed ID: 3117537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa.
    Zhao WH; Hu ZQ
    Crit Rev Microbiol; 2010 Aug; 36(3):245-58. PubMed ID: 20482453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms.
    Gade PAV; Olsen TB; Jensen PØ; Kolpen M; Høiby N; Henneberg KÅ; Sams T
    PLoS One; 2018; 13(6):e0198909. PubMed ID: 29902223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
    Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
    Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assay of beta-lactamase activity in Pseudomonas aeruginosa biofilm].
    Gu X; Li S; Zhang Z
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):585-8. PubMed ID: 11758236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muropeptides in Pseudomonas aeruginosa and their Role as Elicitors of β-Lactam-Antibiotic Resistance.
    Lee M; Dhar S; De Benedetti S; Hesek D; Boggess B; Blázquez B; Mathee K; Mobashery S
    Angew Chem Int Ed Engl; 2016 Jun; 55(24):6882-6. PubMed ID: 27111486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure.
    Ropy A; Cabot G; Sánchez-Diener I; Aguilera C; Moya B; Ayala JA; Oliver A
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3925-34. PubMed ID: 25896695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains.
    Giwercman B; Lambert PA; Rosdahl VT; Shand GH; Høiby N
    J Antimicrob Chemother; 1990 Aug; 26(2):247-59. PubMed ID: 2170321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics.
    Thabaut A; Philippon A; Meyran M
    Chemioterapia; 1985 Feb; 4(1):36-42. PubMed ID: 3921265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa.
    Nichols WW; Evans MJ; Slack MP; Walmsley HL
    J Gen Microbiol; 1989 May; 135(5):1291-303. PubMed ID: 2516117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of β-lactam resistance among Pseudomonas aeruginosa.
    Wolter DJ; Lister PD
    Curr Pharm Des; 2013; 19(2):209-22. PubMed ID: 22894618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of beta-lactam agents (carbapenem excepted) against Pseudomonas aeruginosa strains with CARB or OXA beta-lactamases.
    Bert F; Branger C; Lambert-Zechovsky N
    Chemotherapy; 2004 Apr; 50(1):31-4. PubMed ID: 15084803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of a monocyclic beta-lactam SQ 26,776.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():111-22. PubMed ID: 6799479
    [No Abstract]   [Full Text] [Related]  

  • 19. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.
    Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.
    Sacha P; Wieczorek P; Hauschild T; Zórawski M; Olszańska D; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(2):137-42. PubMed ID: 18519228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.